Upgrades/Downgrades
Updated: 06-Oct-26 09:45 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Dollar General | DG | Gordon Haskett | Hold » Buy | $140 | |
| XP | XP | Itau BBA | Market Perform » Outperform | $27 | |
| Rio Tinto | RIO | RBC Capital Mkts | Underperform » Sector Perform | ||
| Rezolute | RZLT | Cantor Fitzgerald | Neutral » Overweight | ||
| Qiagen | QGEN | Barclays | Equal Weight » Overweight | $55 | |
| Procter & Gamble | PG | Evercore ISI | In-line » Outperform | $166 | |
| PENN Entertainment | PENN | Deutsche Bank | Hold » Buy | $25 | |
| NeoGenomics | NEO | BTIG Research | Neutral » Buy | $28 | |
| MYR Group | MYRG | Jefferies | Hold » Buy | $370 | |
| JetBlue Airways | JBLU | Citigroup | Sell » Neutral | $4.50 | |
| Fortrea | FTRE | Barclays | Equal Weight » Overweight | $23 | |
| Crescent Biopharma | CBIO | H.C. Wainwright | Neutral » Buy | $36 | |
| Corteva | CTVA | JP Morgan | Neutral » Overweight | $19 | |
| Cleveland-Cliffs | CLF | Wells Fargo | Equal Weight » Overweight | $14 | |
| Chain Bridge Bancorp | CBNA | Raymond James | Mkt Perform » Outperform | $53 | |
| Boyd Gaming | BYD | Deutsche Bank | Hold » Buy | $99 | |
| BorgWarner | BWA | Morgan Stanley | Equal-Weight » Overweight | $95 | |
| Amentum Holdings | AMTM | BNP Paribas Exane | Underperform » Neutral | $20 | |
| Skyworks | SWKS | B. Riley Securities | Neutral » Buy | $107 | |
| Old Second Bancorp Inc. | OSBC | Raymond James | Outperform » Strong Buy | $30 | |
| Old National Bancorp | ONB | Raymond James | Mkt Perform » Outperform | $29 | |
| Prosperity Bancshares | PB | Raymond James | Mkt Perform » Outperform | $78 | |
| First Merchants | FRME | Raymond James | Mkt Perform » Outperform | $46 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| BioRestorative Therapies | BRTX | Maxim Group | Buy » Hold | ||
| Ferrovial SE | FER | JP Morgan | Overweight » Neutral | ||
| Personalis | PSNL | BTIG Research | Buy » Neutral | ||
| NIKE | NKE | Berenberg | Hold » Sell | $27.50 | |
| Goosehead Insurance | GSHD | Piper Sandler | Overweight » Neutral | $48 | |
| Gentex | GNTX | Goldman | Neutral » Sell | $20 | |
| CACI Intl | CACI | BNP Paribas Exane | Neutral » Underperform | ||
| WesBanco Inc | WSBC | Raymond James | Strong Buy » Mkt Perform | ||
| Hilltop Holdings | HTH | Raymond James | Mkt Perform » Underperform | ||
| Fulton Fincl | FULT | Raymond James | Outperform » Mkt Perform | ||
| ServisFirst Bancshares | SFBS | Raymond James | Strong Buy » Outperform | $45 | |
| First Bancorp | FBNC | Raymond James | Strong Buy » Outperform | $71 | |
| SentinelOne | S | FBN Securities | Outperform » Sector Perform | $24 | |
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Vylor | VYLR | Oppenheimer | Outperform | $82 | |
| Trex | TREX | Melius | Buy | $62 | |
| Toll Brothers | TOL | Melius | Buy | $179 | |
| Standard Nuclear | STDN | Needham | Buy | $18 | |
| SPX Technologies | SPXC | Robert W. Baird | Outperform | $220 | |
| Sherwin-Williams | SHW | Melius | Hold | $367 | |
| Revvity | RVTY | William Blair | Outperform | ||
| Rapport Therapeutics | RAPP | Guggenheim | Buy | $65 | |
| QXO, Inc | QXO | Melius | Buy | $17 | |
| PulteGroup | PHM | Melius | Hold | $132 | |
| Owens Corning | OC | Melius | Sell | $118 | |
| Ovid Therapeutics | OVID | Guggenheim | Buy | $7 | |
| Northrop Grumman | NOC | Rothschild & Co Redburn | Buy | $680 | |
| Mohawk | MHK | Melius | Buy | $188 | |
| Modine Manufacturing | MOD | Robert W. Baird | Outperform | $300 | |
| Meritage | MTH | Melius | Sell | $59 | |
| Masco | MAS | Melius | Hold | $75 | |
| MapLight Therapeutics | MPLT | Guggenheim | Neutral | ||
| Lockheed Martin | LMT | Rothschild & Co Redburn | Buy | $650 | |
| Lennar | LEN | Melius | Sell | $72 | |
| LB Pharmaceuticals | LBRX | Guggenheim | Buy | $80 | |
| Lattice Semi | LSCC | William Blair | Outperform | ||
| Kratos Defense and Security | KTOS | Rothschild & Co Redburn | Buy | $70 | |
| KB Home | KBH | Melius | Sell | $43 | |
| James Hardie | JHX | Melius | Buy | $36 | |
| Intellia Therapeutics | NTLA | Barclays | Underweight | $8 | |
| Installed Building Products | IBP | Melius | Hold | $217 | |
| Fortune Brands Innovations | FBIN | Melius | Hold | $44 | |
| Ferguson Enterprises | FERG | Melius | Hold | $252 | |
| Zegna Group | ZGN | HSBC Securities | Buy | $16 | |
| Diodes | DIOD | BofA Securities | Buy | $135 | |
| D.R. Horton | DHI | Melius | Sell | $128 | |
| Builders FirstSource | BLDR | Melius | Sell | $52 | |
| AvePoint | AVPT | BMO Capital Markets | Outperform | $17 | |
| AeroVironment | AVAV | Rothschild & Co Redburn | Neutral | $165 | |
| Rum Group | RUM | Lake Street | Hold | $25 | |
| Envoy Medical | COCH | Lake Street | Buy | $2.50 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Xenon Pharmaceuticals | XENE | Guggenheim | Buy | $73 | |
| Neurocrine Biosciences | NBIX | Guggenheim | Buy | $207 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |